IL6 and prostate carcinoma: Bone morphogenetic protein (BMP)-6 released by prostate cancer cells stimulates M2-type-TAMs to produce IL-6 [32], while tumor-infiltrating M2-type-TAMs promote NED development by activating downstream IL-6 signaling [33].